Mycobacterium Ulcerans Drug Resistance
Antibiotics not effective against Mycobacterium ulcerans infection
Published in Medical Letter on the CDC and FDA, July 2nd, 2006
"The skin disease Buruli ulcer, caused by Mycobacterium ulcerans, is the third most common mycobacterial disease after tuberculosis and leprosy and mainly affects remote rural African communities.
"Although the disease is known to be linked to contaminated water, the mode of transmission is not yet understood, which makes it difficult to propose control interventions. The disease is usually detected in its later stages, when it has caused substantial damage and disability," scientists in England report.
According to the authors, "Surgery remains...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Disease Control
Pediatric pneumococcal vaccination decreases adult Streptococcus pneumoniae - Drug Safety
Allometric methods to predict drug clearance in children are compared - Information Technology
Health survey estimates are impacted by substitution of cell phones for land lines - Osteoporosis
Effects of progestogen-only contraceptive drugs on bone mineral density are reviewed - Public Health
Delayed childbearing may contribute to trend in low birthweight rates - Adverse Drug Reaction
Clinical features of gemcitabine-associated lung injury are described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
